The Food and Drug Administration (“FDA”) said on Thursday that they will seek to pull the common ingredient phenylephrine off ...

In a long-sought move, the Food and Drug Administration on Thursday formally began the process of abandoning oral doses of a ...

A deviated septum occurs when you have two different-sized nasal passageways which can cause one-sided congestion.

Citing topline data from their Phase 3 WAYPOINT trial, the companies said that the antibody therapy reduced the size of nasal ...

A common ingredient found in most oral over-the-counter cold medicines should be removed from the market because it doesn’t ...

The U.S. Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups, as an ...

The agency said an extensive review of available data determined that the ingredient, oral phenylephrine, doesn’t actually ...

The US Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups.

Amgen (NASDAQ:AMGN) and AstraZeneca today announced positive top-line results from the Phase 3 WAYPOINT trial in patients ...

The FDA would provide manufacturers with appropriate time to either reformulate drugs containing oral phenylephrine or remove ...